Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study
-
Published:2023-08
Issue:8
Volume:34
Page:670-680
-
ISSN:0923-7534
-
Container-title:Annals of Oncology
-
language:en
-
Short-container-title:Annals of Oncology
Author:
Oliveira M., Falato C., Cejalvo J.M., Vila M. MargelíORCID, Tolosa P., Salvador-Bofill F.J., Cruz J., Arumi M., Luna A.M., Guerra J.A., Vidal M., Martínez-Sáez O., Paré L., González-Farré B., Sanfeliu E., Ciruelos E., Espinosa-Bravo M., Pernas S., Izarzugaza Y., Esker S., Fan P.-D., Parul P., Santhanagopal A., Sellami D., Villacampa G., Ferrero-Cafiero J.M., Pascual T., Prat A.
Funder
Daiichi Sankyo Co Ltd
Subject
Oncology,Hematology
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|